benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide has been researched along with chymostatin in 1 studies
Studies (benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide) | Trials (benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide) | Recent Studies (post-2010) (benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide) | Studies (chymostatin) | Trials (chymostatin) | Recent Studies (post-2010) (chymostatin) |
---|---|---|---|---|---|
48 | 0 | 6 | 167 | 0 | 14 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rosenthal, PJ | 1 |
1 other study(ies) available for benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide and chymostatin
Article | Year |
---|---|
Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites.
Topics: Animals; Antimalarials; Chymotrypsin; Coumarins; Cysteine Proteinase Inhibitors; Dipeptides; Electrophoresis, Polyacrylamide Gel; Erythrocytes; Fluorescent Dyes; Globins; Humans; Hydrolysis; Leucine; Leupeptins; Oligopeptides; Pepstatins; Plasmodium falciparum; Vacuoles | 1995 |